QR Kodea

Glucagon-like peptide-1 receptor agonists for weight loss in end-stage heart failure patients considered for heart transplantation

Severe obesity is a relative exclusion criterion for heart transplantation. This study assessed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss as a bridge to heart transplantation candidacy. A retrospective study of end-stage heart failure (ESHF) outpatients commenced on semag...

Deskribapen osoa

Gorde:
Egile Nagusiak: Sambavan Jeyakumar, BMed, MD, Ragavi Jeyakumar, BMed, MD, Hunter Eckford, BMedSc, Desiree Robson, RN, Liarna Honeysett, RN, Lisa Raven, MBBS, Ricardo Deveza, MD, Andrew Jabbour, MBBS, PhD, Eugene Kotlyar, MBBS, MD, Anne Keogh, MBBS, MD, Jerry R. Greenfield, MBBS, PhD, Peter Macdonald, MD, PhD, Christopher Hayward, MBBS, MD, Kavitha Muthiah, MBChB, PhD
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2026-08-01
Saila:JHLT Open
Gaiak:
Heart transplantation
Transplant candidacy
GLP-1 receptor agonists
Weight loss
Pre-transplant optimization
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2950133426000807
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak